グローバル長時間作用型減量薬市場規模、主要企業シェア、ランキング分析レポート【2026年版】

Long-acting Weight Loss Drugs - Global Top Players Market Share and Ranking 2026

レポートID：
224073
発表時期：
2026-03-03
レポート形式：
PDF
産業カテゴリー：
薬品及びサプリメント
レポート言語：
英語、日本語
ページ数：
101
発行会社（調査会社）：
YHResearch

レポートの概要

本報告書は、世界の長時間作用型減量薬市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点から長時間作用型減量薬市場を分析し、需要構造と成長特性を明確化します。
長時間作用型減量薬市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、長時間作用型減量薬に関する的確な意思決定を行うための実践的なインサイトを提供します。

 主要長時間作用型減量薬市場の統計
2025年世界市場規模：5257百万米ドル
2026年世界市場規模：5559百万米ドル
2032年予測市場規模：7889百万米ドル
2026–2032年予測期間CAGR：6.0%
本レポートは長時間作用型減量薬市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。 
【市場セグメンテーション】
主要企業・競争環境
長時間作用型減量薬市場の主要企業には以下が含まれます：
Novo Nordisk
Roche
GSK
Vivus
Arena
Orexigen 

製品別
Orlistat
Semaglutide
Liraglutide
Other 

アプリケーション別
Hospital
Clinic
Other 

レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他

レポート構成（章別概要）
第1章｜市場概要と成長展望
長時間作用型減量薬市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
長時間作用型減量薬市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別に長時間作用型減量薬市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別に長時間作用型減量薬市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、長時間作用型減量薬市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章｜国別市場動向
主要国・地域ごとに、長時間作用型減量薬市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
長時間作用型減量薬市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します

本レポートの要点と洞察
 長時間作用型減量薬市場の全体像と成長見通し
長時間作用型減量薬市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境が長時間作用型減量薬市場に与える影響を分析いたします
 市場環境の構成要素とマクロトレンド
長時間作用型減量薬産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
 競争構造と主要企業の動向分析
長時間作用型減量薬市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
 競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点から長時間作用型減量薬市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
 成長要因・課題・リスクの分析
長時間作用型減量薬市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
 将来トレンドと市場展望
長時間作用型減量薬市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします

Description

According to YH Research, the global market for Long-acting Weight Loss Drugs should grow from US$ 5257 million in 2025 to US$ 7889 million by 2032, with a CAGR of 6.0% for the period of 2026-2032.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Long-acting weight loss drugs, also known as extended-release or sustained-release weight loss medications, are pharmaceuticals designed to help individuals manage their weight by reducing appetite, increasing feelings of fullness, or altering the body"s metabolism over an extended period. These drugs are formulated to provide more sustained effects, allowing for less frequent dosing. It"s essential to note that these medications are typically prescribed under the guidance of a healthcare professional and are intended for use as part of a comprehensive weight management program.

The market for long-acting weight loss drugs is experiencing rapid growth, driven by global concerns about obesity and an ongoing pursuit of healthy lifestyles. The market size has significantly expanded, with increasing sales. The specific uses of long-acting weight loss drugs primarily involve assisting individuals who struggle to achieve their ideal weight through traditional methods. These drugs work by regulating appetite, promoting metabolism, or affecting energy absorption to achieve long-term weight loss. In the future, with ongoing technological innovations and an increasing awareness of health, the development and application of long-acting weight loss drugs are expected to continue progressing, offering more solutions to the global obesity issue.

This report studies and analyses global Long-acting Weight Loss Drugs status and future trends, helps the client to determine the Long-acting Weight Loss Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Long-acting Weight Loss Drugs, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Long-acting Weight Loss Drugs market size, history data 2021-2025, and forecast data 2026-2032, (US$ million) & (K Units)
(2) Global Long-acting Weight Loss Drugs sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (K Units)
(3) Japan Long-acting Weight Loss Drugs sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (K Units)
(4) Global Long-acting Weight Loss Drugs key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Long-acting Weight Loss Drugs key producing regions, capacity, production, and year over year growth
(6) Long-acting Weight Loss Drugs industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Novo Nordisk
    Roche
    GSK
    Vivus
    Arena
    Orexigen

Market segment by Type, covers
    Orlistat
    Semaglutide
    Liraglutide
    Other

Market segment by Application, can be divided into
    Hospital
    Clinic
    Other

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Long-acting Weight Loss Drugs product scope, global sales quantity, value and average price, Japan sales quantity, value and average price, development opportunities, challenges, trends, and policies
Chapter 2: Global Long-acting Weight Loss Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 3: Japan Long-acting Weight Loss Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 4: Global key producing regions of Long-acting Weight Loss Drugs, percent & CAGR, 2021-2032
Chapter 5: Long-acting Weight Loss Drugs industry chain, upstream, medium-stream, and downstream
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin
Chapter 11: Conclusions

Table of Contents

1 Market Overview
    1.1 Long-acting Weight Loss Drugs Definition
    1.2 Global Long-acting Weight Loss Drugs Market Size and Forecast
        1.2.1 By Consumption Value, Global Long-acting Weight Loss Drugs Market Size, 2021-2032
        1.2.2 By Sales Quantity, Global Long-acting Weight Loss Drugs Market Size, 2021-2032
        1.2.3 Global Long-acting Weight Loss Drugs Average Selling Price (ASP), 2021-2032
    1.3 Japan Long-acting Weight Loss Drugs Market Size and Forecast
        1.3.1 By Consumption Value, Japan Long-acting Weight Loss Drugs Market Size, 2021-2032
        1.3.2 By Sales Quantity, Japan Long-acting Weight Loss Drugs Market Size, 2021-2032
        1.3.3 Japan Long-acting Weight Loss Drugs Average Selling Price (ASP), 2021-2032
    1.4 Share of Japan Long-acting Weight Loss Drugs Market with Respect to the Global Market
        1.4.1 By Consumption Value, Japan Long-acting Weight Loss Drugs Market Share in Global, 2021-2032
        1.4.2 By Sales Quantity, Japan Long-acting Weight Loss Drugs Market Share in Global, 2021-2032
        1.4.3 Long-acting Weight Loss Drugs Market Size: Japan VS Global, 2021-2032
    1.5 Long-acting Weight Loss Drugs Market Dynamics
        1.5.1 Long-acting Weight Loss Drugs Market Drivers
        1.5.2 Long-acting Weight Loss Drugs Market Restraints
        1.5.3 Long-acting Weight Loss Drugs Industry Trends
        1.5.4 Long-acting Weight Loss Drugs Industry Policy

2 Global Leading Manufacturers and Market Share
    2.1 By Revenue of Long-acting Weight Loss Drugs, Global Market Share by Company, 2021-2026
    2.2 By Sales Quantity of Long-acting Weight Loss Drugs, Global Market Share by Company, 2021-2026
    2.3 Long-acting Weight Loss Drugs Average Selling Price (ASP) by Company, 2021-2026
    2.4 Global Long-acting Weight Loss Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.5 Global Long-acting Weight Loss Drugs Concentration Ratio
    2.6 Global Long-acting Weight Loss Drugs Mergers & Acquisitions, Expansion Plans
    2.7 Global Long-acting Weight Loss Drugs Manufacturers Product Type
    2.8 Head Office and Long-acting Weight Loss Drugs Production Site of Key Manufacturer
    2.9 Long-acting Weight Loss Drugs Capacity of Major Manufacturers and Future Plan

3 Japan Leading Manufacturers and Market Share
    3.1 By Revenue of Long-acting Weight Loss Drugs, Japan Market Share by Company, 2021-2026
    3.2 By Sales Quantity of Long-acting Weight Loss Drugs, Japan Market Share by Company, 2021-2026
    3.3 Japan Long-acting Weight Loss Drugs Long-acting Weight Loss Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
    4.1 Global Long-acting Weight Loss Drugs Capacity, Output and Capacity Utilization, 2021-2032
    4.2 Global Long-acting Weight Loss Drugs Capacity by Region
    4.3 Global Long-acting Weight Loss Drugs Production & Forecast by Region, 2021 VS 2025 VS 2032
    4.4 Global Long-acting Weight Loss Drugs Production by Region, 2021-2032
    4.5 Global Long-acting Weight Loss Drugs Production Market Share & Forecast by Region, 2021-2032

5 Industry Chain Analysis
    5.1 Long-acting Weight Loss Drugs Industry Chain
    5.2 Long-acting Weight Loss Drugs Upstream Analysis
        5.2.1 Long-acting Weight Loss Drugs Core Raw Materials
        5.2.2 Main Manufacturers of Long-acting Weight Loss Drugs Core Raw Materials
    5.3 Midstream Analysis
    5.4 Downstream Analysis
    5.5 Long-acting Weight Loss Drugs Production Mode
    5.6 Long-acting Weight Loss Drugs Procurement Model
    5.7 Long-acting Weight Loss Drugs Industry Sales Model and Sales Channels
        5.7.1 Long-acting Weight Loss Drugs Sales Model
        5.7.2 Long-acting Weight Loss Drugs Typical Distributors

6 Sights by Type
    6.1 Long-acting Weight Loss Drugs Classification by Type
        6.1.1 Orlistat
        6.1.2 Semaglutide
        6.1.3 Liraglutide
        6.1.4 Other
    6.2 by Type, Global Long-acting Weight Loss Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032
    6.3 by Type, Global Long-acting Weight Loss Drugs Consumption Value, 2021-2032
    6.4 by Type, Global Long-acting Weight Loss Drugs Sales Quantity, 2021-2032
    6.5 by Type, Global Long-acting Weight Loss Drugs Average Selling Price (ASP), 2021-2032

7 Sights by Application
    7.1 Long-acting Weight Loss Drugs Segment by Application
        7.1.1 Hospital
        7.1.2 Clinic
        7.1.3 Other
    7.2 by Application, Global Long-acting Weight Loss Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032
    7.3 by Application, Global Long-acting Weight Loss Drugs Consumption Value, 2021-2032
    7.4 by Application, Global Long-acting Weight Loss Drugs Sales Quantity, 2021-2032
    7.5 by Application, Global Long-acting Weight Loss Drugs Price, 2021-2032

8 Sales Sights by Region
    8.1 By Region, Global Long-acting Weight Loss Drugs Consumption Value, 2021 VS 2025 VS 2032
    8.2 By Region, Global Long-acting Weight Loss Drugs Consumption Value, 2021-2032
    8.3 By Region, Global Long-acting Weight Loss Drugs Sales Quantity, 2021-2032
    8.4 North America
        8.4.1 North America Long-acting Weight Loss Drugs Market Size & Forecasts, 2021-2032
        8.4.2 By Country, North America Long-acting Weight Loss Drugs Market Size Market Share
    8.5 Europe
        8.5.1 Europe Long-acting Weight Loss Drugs Market Size & Forecasts, 2021-2032
        8.5.2 By Country, Europe Long-acting Weight Loss Drugs Market Size Market Share
    8.6 Asia Pacific
        8.6.1 Asia Pacific Long-acting Weight Loss Drugs Market Size & Forecasts, 2021-2032
        8.6.2 By Country/Region, Asia Pacific Long-acting Weight Loss Drugs Market Size Market Share
    8.7 South America
        8.7.1 South America Long-acting Weight Loss Drugs Market Size & Forecasts, 2021-2032
        8.7.2 By Country, South America Long-acting Weight Loss Drugs Market Size Market Share
    8.8 Middle East & Africa

9 Sales Sights by Country Level
    9.1 By Country, Global Long-acting Weight Loss Drugs Market Size & CAGR, 2021 VS 2025 VS 2032
    9.2 By Country, Global Long-acting Weight Loss Drugs Consumption Value, 2021-2032
    9.3 By Country, Global Long-acting Weight Loss Drugs Sales Quantity, 2021-2032
    9.4 United States
        9.4.1 United States Long-acting Weight Loss Drugs Market Size, 2021-2032
        9.4.2 by Type, United States Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
        9.4.3 by Application, United States Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
    9.5 Europe
        9.5.1 Europe Long-acting Weight Loss Drugs Market Size, 2021-2032
        9.5.2 by Type, Europe Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
        9.5.3 by Application, Europe Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
    9.6 China
        9.6.1 China Long-acting Weight Loss Drugs Market Size, 2021-2032
        9.6.2 by Type, China Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
        9.6.3 by Application, China Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
    9.7 Japan
        9.7.1 Japan Long-acting Weight Loss Drugs Market Size, 2021-2032
        9.7.2 by Type, Japan Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
        9.7.3 by Application, Japan Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
    9.8 South Korea
        9.8.1 South Korea Long-acting Weight Loss Drugs Market Size, 2021-2032
        9.8.2 by Type, South Korea Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
        9.8.3 by Application, South Korea Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
    9.9 Southeast Asia
        9.9.1 Southeast Asia Long-acting Weight Loss Drugs Market Size, 2021-2032
        9.9.2 by Type, Southeast Asia Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
        9.9.3 by Application, Southeast Asia Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
    9.10 India
        9.10.1 India Long-acting Weight Loss Drugs Market Size, 2021-2032
        9.10.2 by Type, India Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
        9.10.3 by Application, India Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
    9.11 Middle East & Africa
        9.11.1 Middle East & Africa Long-acting Weight Loss Drugs Market Size, 2021-2032
        9.11.2 by Type, Middle East & Africa Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
        9.11.3 by Application, Middle East & Africa Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032

10 Manufacturers Profile
    10.1 Novo Nordisk
        10.1.1 Novo Nordisk Company Information, Head Office, Market Area, and Industry Position
        10.1.2 Novo Nordisk Long-acting Weight Loss Drugs Models, Specifications, and Application
        10.1.3 Novo Nordisk Long-acting Weight Loss Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.1.4 Novo Nordisk Company Profile and Main Business
        10.1.5 Novo Nordisk Recent Developments
    10.2 Roche
        10.2.1 Roche Company Information, Head Office, Market Area, and Industry Position
        10.2.2 Roche Long-acting Weight Loss Drugs Models, Specifications, and Application
        10.2.3 Roche Long-acting Weight Loss Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.2.4 Roche Company Profile and Main Business
        10.2.5 Roche Recent Developments
    10.3 GSK
        10.3.1 GSK Company Information, Head Office, Market Area, and Industry Position
        10.3.2 GSK Long-acting Weight Loss Drugs Models, Specifications, and Application
        10.3.3 GSK Long-acting Weight Loss Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.3.4 GSK Company Profile and Main Business
        10.3.5 GSK Recent Developments
    10.4 Vivus
        10.4.1 Vivus Company Information, Head Office, Market Area, and Industry Position
        10.4.2 Vivus Long-acting Weight Loss Drugs Models, Specifications, and Application
        10.4.3 Vivus Long-acting Weight Loss Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.4.4 Vivus Company Profile and Main Business
        10.4.5 Vivus Recent Developments
    10.5 Arena
        10.5.1 Arena Company Information, Head Office, Market Area, and Industry Position
        10.5.2 Arena Long-acting Weight Loss Drugs Models, Specifications, and Application
        10.5.3 Arena Long-acting Weight Loss Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.5.4 Arena Company Profile and Main Business
        10.5.5 Arena Recent Developments
    10.6 Orexigen
        10.6.1 Orexigen Company Information, Head Office, Market Area, and Industry Position
        10.6.2 Orexigen Long-acting Weight Loss Drugs Models, Specifications, and Application
        10.6.3 Orexigen Long-acting Weight Loss Drugs Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
        10.6.4 Orexigen Company Profile and Main Business
        10.6.5 Orexigen Recent Developments

11 Conclusion

12 Appendix
    12.1 Research Methodology
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Market Estimation Model
    12.4 Disclaimer

Table of Figures

List of Tables
Table 1. Long-acting Weight Loss Drugs Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million
Table 2. Long-acting Weight Loss Drugs Market Restraints
Table 3. Long-acting Weight Loss Drugs Market Trends
Table 4. Long-acting Weight Loss Drugs Industry Policy
Table 5. Global Long-acting Weight Loss Drugs Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
Table 6. Global Long-acting Weight Loss Drugs Revenue Share by Company, 2021-2026, Ranked by Data of 2025
Table 7. Global Long-acting Weight Loss Drugs Sales Quantity by Company, (2021-2026) & (K Units), Ranked Based on Sales in 2025
Table 8. Global Long-acting Weight Loss Drugs Sales Quantity Market Share by Company, 2021-2026, Ranked by Data of 2025
Table 9. Global Long-acting Weight Loss Drugs Average Selling Price (ASP) by Company, (2021-2026) & (US$/Unit)
Table 10. Global Long-acting Weight Loss Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Long-acting Weight Loss Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Long-acting Weight Loss Drugs Manufacturers Product Type
Table 13. Head Office and Long-acting Weight Loss Drugs Production Site of Key Manufacturer
Table 14. Long-acting Weight Loss Drugs Capacity of Major Manufacturers and Future Plan
Table 15. Japan Long-acting Weight Loss Drugs Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
Table 16. Japan Long-acting Weight Loss Drugs Revenue Share by Company, 2021-2026, Ranked by Data of 2025
Table 17. Japan Long-acting Weight Loss Drugs Sales Quantity by Company, (2021-2026) & (K Units), Ranked Based on Sales in 2025
Table 18. Japan Long-acting Weight Loss Drugs Sales Quantity Market Share by Company, 2021-2026, Ranked by Data of 2025
Table 19. Global Long-acting Weight Loss Drugs Production & Forecast by Region, 2021 VS 2025 VS 2032, (K Units)
Table 20. Global Long-acting Weight Loss Drugs Production by Region, 2021-2026, (K Units)
Table 21. Global Long-acting Weight Loss Drugs Production Forecast by Region, 2027-2032, (K Units)
Table 22. Global Key Players of Long-acting Weight Loss Drugs Upstream (Raw Materials)
Table 23. Global Long-acting Weight Loss Drugs Typical Customers
Table 24. Long-acting Weight Loss Drugs Typical Distributors
Table 25. by Type, Global Long-acting Weight Loss Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
Table 26. by Application, Global Long-acting Weight Loss Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
Table 27. By Region, Global Long-acting Weight Loss Drugs Consumption Value, 2021 VS 2025 VS 2032, US$ Million
Table 28. By Region, Global Long-acting Weight Loss Drugs Consumption Value, 2021-2032, US$ Million
Table 29. By Region, Global Long-acting Weight Loss Drugs Sales Quantity, 2021-2032, (K Units)
Table 30. By Country, Global Long-acting Weight Loss Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
Table 31. By Country, Global Long-acting Weight Loss Drugs Consumption Value, 2021-2032, US$ Million
Table 32. By Country, Global Long-acting Weight Loss Drugs Consumption Value Market Share, 2021-2032
Table 33. By Country, Global Long-acting Weight Loss Drugs Sales Quantity, 2021-2032, (K Units)
Table 34. By Country, Global Long-acting Weight Loss Drugs Sales Quantity Market Share, 2021-2032
Table 35. Novo Nordisk Company Information, Head Office, Market Area, and Industry Position
Table 36. Novo Nordisk Long-acting Weight Loss Drugs Models, Specifications, and Application
Table 37. Novo Nordisk Long-acting Weight Loss Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 38. Novo Nordisk Company Profile and Main Business
Table 39. Novo Nordisk Recent Developments
Table 40. Roche Company Information, Head Office, Market Area, and Industry Position
Table 41. Roche Long-acting Weight Loss Drugs Models, Specifications, and Application
Table 42. Roche Long-acting Weight Loss Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 43. Roche Company Profile and Main Business
Table 44. Roche Recent Developments
Table 45. GSK Company Information, Head Office, Market Area, and Industry Position
Table 46. GSK Long-acting Weight Loss Drugs Models, Specifications, and Application
Table 47. GSK Long-acting Weight Loss Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 48. GSK Company Profile and Main Business
Table 49. GSK Recent Developments
Table 50. Vivus Company Information, Head Office, Market Area, and Industry Position
Table 51. Vivus Long-acting Weight Loss Drugs Models, Specifications, and Application
Table 52. Vivus Long-acting Weight Loss Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 53. Vivus Company Profile and Main Business
Table 54. Vivus Recent Developments
Table 55. Arena Company Information, Head Office, Market Area, and Industry Position
Table 56. Arena Long-acting Weight Loss Drugs Models, Specifications, and Application
Table 57. Arena Long-acting Weight Loss Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 58. Arena Company Profile and Main Business
Table 59. Arena Recent Developments
Table 60. Orexigen Company Information, Head Office, Market Area, and Industry Position
Table 61. Orexigen Long-acting Weight Loss Drugs Models, Specifications, and Application
Table 62. Orexigen Long-acting Weight Loss Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026
Table 63. Orexigen Company Profile and Main Business
Table 64. Orexigen Recent Developments

List of Figures
Figure 1. Long-acting Weight Loss Drugs Picture
Figure 2. Global Long-acting Weight Loss Drugs Consumption Value, (US$ million) & (2021-2032)
Figure 3. Global Long-acting Weight Loss Drugs Sales Quantity, (K Units) & (2021-2032)
Figure 4. Global Long-acting Weight Loss Drugs Average Selling Price (ASP), (2021-2032) & (US$/Unit)
Figure 5. Japan Long-acting Weight Loss Drugs Consumption Value, (US$ million) & (2021-2032)
Figure 6. Japan Long-acting Weight Loss Drugs Sales Quantity (K Units) & (2021-2032)
Figure 7. Japan Long-acting Weight Loss Drugs Average Selling Price (ASP), (US$/Unit) & (2021-2032)
Figure 8. By Consumption Value, Japan Long-acting Weight Loss Drugs Market Share of Global, 2021-2032
Figure 9. By Sales Quantity, Japan Long-acting Weight Loss Drugs Market Share of Global, 2021-2032
Figure 10. Global Long-acting Weight Loss Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025
Figure 11. Japan Long-acting Weight Loss Drugs Key Participants, Market Share, 2025
Figure 12. Global Long-acting Weight Loss Drugs Capacity, Production and Capacity Utilization, 2021-2032
Figure 13. Global Long-acting Weight Loss Drugs Capacity Market Share by Region, 2025 VS 2032
Figure 14. Global Long-acting Weight Loss Drugs Production Market Share & Forecast by Region, 2021-2032
Figure 15. Long-acting Weight Loss Drugs Industry Chain
Figure 16. Long-acting Weight Loss Drugs Procurement Model
Figure 17. Long-acting Weight Loss Drugs Sales Model
Figure 18. Long-acting Weight Loss Drugs Sales Channels, Direct Sales, and Distribution
Figure 19. Orlistat
Figure 20. Semaglutide
Figure 21. Liraglutide
Figure 22. Other
Figure 23. by Type, Global Long-acting Weight Loss Drugs Consumption Value, 2021-2032, US$ Million
Figure 24. by Type, Global Long-acting Weight Loss Drugs Consumption Value Market Share, 2021-2032
Figure 25. by Type, Global Long-acting Weight Loss Drugs Sales Quantity, 2021-2032, (K Units)
Figure 26. by Type, Global Long-acting Weight Loss Drugs Sales Quantity Market Share, 2021-2032
Figure 27. by Type, Global Long-acting Weight Loss Drugs Average Selling Price (ASP), 2021-2032, (US$/Unit)
Figure 28. Hospital
Figure 29. Clinic
Figure 30. Other
Figure 31. by Application, Global Long-acting Weight Loss Drugs Consumption Value, 2021-2032, US$ Million
Figure 32. by Application, Global Long-acting Weight Loss Drugs Revenue Market Share, 2021-2032
Figure 33. by Application, Global Long-acting Weight Loss Drugs Sales Quantity, 2021-2032, (K Units)
Figure 34. by Application, Global Long-acting Weight Loss Drugs Sales Quantity Market Share, 2021-2032
Figure 35. by Application, Global Long-acting Weight Loss Drugs Price, 2021-2032, (US$/Unit)
Figure 36. By Region, Global Long-acting Weight Loss Drugs Consumption Value Market Share, 2021-2032
Figure 37. By Region, Global Long-acting Weight Loss Drugs Sales Quantity Market Share, 2021-2032
Figure 38. North America Long-acting Weight Loss Drugs Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 39. By Country, North America Long-acting Weight Loss Drugs Consumption Value Market Share, 2025
Figure 40. Europe Long-acting Weight Loss Drugs Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 41. By Country, Europe Long-acting Weight Loss Drugs Consumption Value Market Share, 2025
Figure 42. Asia Pacific Long-acting Weight Loss Drugs Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 43. By Country/Region, Asia Pacific Long-acting Weight Loss Drugs Consumption Value Market Share, 2025
Figure 44. South America Long-acting Weight Loss Drugs Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 45. By Country, South America Long-acting Weight Loss Drugs Consumption Value Market Share, 2025
Figure 46. Middle East & Africa Long-acting Weight Loss Drugs Consumption Value & Forecasts, 2021-2032, US$ Million
Figure 47. United States Long-acting Weight Loss Drugs Sales Quantity, 2021-2032, (K Units)
Figure 48. by Type, United States Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 49. by Application, United States Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 50. Europe Long-acting Weight Loss Drugs Sales Quantity, 2021-2032, (K Units)
Figure 51. by Type, Europe Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 52. by Application, Europe Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 53. China Long-acting Weight Loss Drugs Sales Quantity, 2021-2032, (K Units)
Figure 54. by Type, China Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 55. by Application, China Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 56. Japan Long-acting Weight Loss Drugs Sales Quantity, 2021-2032, (K Units)
Figure 57. by Type, Japan Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 58. by Application, Japan Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 59. South Korea Long-acting Weight Loss Drugs Sales Quantity, 2021-2032, (K Units)
Figure 60. by Type, South Korea Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 61. by Application, South Korea Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 62. Southeast Asia Long-acting Weight Loss Drugs Sales Quantity, 2021-2032, (K Units)
Figure 63. by Type, Southeast Asia Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 64. by Application, Southeast Asia Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 65. India Long-acting Weight Loss Drugs Sales Quantity, 2021-2032, (K Units)
Figure 66. by Type, India Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 67. by Application, India Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 68. Middle East & Africa Long-acting Weight Loss Drugs Sales Quantity, 2021-2032, (K Units)
Figure 69. by Type, Middle East & Africa Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 70. by Application, Middle East & Africa Long-acting Weight Loss Drugs Sales Quantity Market Share, 2025 VS 2032
Figure 71. Research Methodology
Figure 72. Breakdown of Primary Interviews
Figure 73. Bottom-up Approaches
Figure 74. Top-down Approaches

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>

当社から購入のメリット

購入方法

※当サイトに掲載されていない海外調査報告書も当社経由でご購入いただけますので、お問い合わせください。

※市場調査レポートの購入や市場調査をご希望の場合は、実績と信頼のある株式会社市場調査センターにお任せください。

*フォーチュン500企業は当社と緊密な協力関係を確立しています

クライアント様（例）